- Report
- May 2023
- 140 Pages
Global
From €4504EUR$4,949USD£3,826GBP
- Report
- April 2023
- 147 Pages
Global
From €4504EUR$4,949USD£3,826GBP
- Report
- October 2022
- 82 Pages
Middle East, Africa
From €1365EUR$1,500USD£1,160GBP
- Report
- July 2020
- 111 Pages
Asia Pacific
From €8187EUR$8,995USD£6,954GBP
- Report
- February 2024
- 380 Pages
Global
€4546EUR$4,995USD£3,861GBP
- Book
- April 2018
- 312 Pages
- Book
- September 2014
- 1880 Pages
- Book
- June 2021
- 464 Pages
- Book
- June 2017
- 424 Pages
- Book
- September 2016
- 680 Pages
- Book
- February 2016
- 1416 Pages
- Book
- August 2015
- 288 Pages
- Book
- November 2011
- 284 Pages
- Book
- March 2008
- 352 Pages

Cellular Transplantation is a form of biotechnology that involves the transfer of cells from one organism to another. It is used to treat a variety of diseases and conditions, including cancer, diabetes, and heart disease. The process involves the extraction of healthy cells from a donor, which are then transplanted into the recipient. The transplanted cells can be used to replace damaged or diseased cells, or to stimulate the body's own immune system to fight off disease.
Cellular Transplantation is a rapidly growing field of biotechnology, with many potential applications. It has the potential to revolutionize the treatment of many diseases, and has already been used to treat a variety of conditions. It is also being explored as a potential treatment for neurological disorders, such as Parkinson's disease.
Companies in the Cellular Transplantation market include Novartis, Celgene, and Astellas Pharma. Other companies involved in the field include BioMarin Pharmaceuticals, Vertex Pharmaceuticals, and Kite Pharma. Show Less Read more